Thiol-modifying inhibitors for understanding squalene cyclase function

被引:12
作者
Milla, P
Lenhart, A
Grosa, G
Viola, F
Weihofen, WA
Schulz, GE
Balliano, G
机构
[1] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy
[2] Univ Freiburg, Inst Organ Chem & Biochem, D-7800 Freiburg, Germany
[3] Univ Studi Piemonte Orientale A Avogadro, Diparitmento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2002年 / 269卷 / 08期
关键词
Alicyclobacillus acidocaldarius; membrane protein; site-directed mutagenesis; squalene cyclase; thiol reagents;
D O I
10.1046/j.1432-1033.2002.02861.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The function of squalene-hopene cyclase from Alicyclobacillus acidocaldarius was studied by labelling critical cysteine residues of the enzyme, either native or inserted by site-directed mutagenesis, with different thiol-reacting molecules. The access of the substrate to the active centre cavity through a nonpolar channel that contains a narrow constriction harbouring a cysteine residue (C435) was probed by labelling experiments on both a C435S mutant, lacking C435 of the channel constriction, and a C25S/C50S/C455S/C537S mutant, bearing C435 as the only cysteine residue. Labelling experiments with tritiated 3-carboxy-4-nitrophenyl-dithiol,1',2-trisnorsqualene (CNDT-squalene) showed that the cysteine residue at the channel constriction was covalently modified by the squalene-like inhibitor. Titre-dependent inactivation of the C25S/C50S/C455S/C537S mutant by a number of squalene analogues and other agents with thiol-modifying activity suggested that modifying C435 caused the obstruction of the channel constriction thus blocking access of the substrate to the active site. The tryptic fragment comprising C435 of the quadruple mutant labelled with the most effective inhibitor had the expected altered molecular mass, as determined by LC-ESI-MS measurements. The arrangement of the substrate in the active site cavity was studied by using thiol reagents as probes in labelling experiments with the double mutant D376C/C435S in which D376, supposedly the substrate-protonating residue, was substituted by cysteine. The inhibitory effect was evaluated in terms of the reduced ability to cyclize oxidosqualene, as the mutant is unable to catalyse the reaction of squalene to hopene. Among the inhibitors tested, the substrate analogue squalene-maleimide proved to be a very effective time-dependent inhibitor.
引用
收藏
页码:2108 / 2116
页数:9
相关论文
共 28 条
[1]   ENZYMATIC CYCLIZATION OF SQUALENE AND OXIDOSQUALENE TO STEROLS AND TRITERPENES [J].
ABE, I ;
ROHMER, M ;
PRESTWICH, GD .
CHEMICAL REVIEWS, 1993, 93 (06) :2189-2206
[2]   CHARACTERIZATION AND PARTIAL-PURIFICATION OF SQUALENE-2,3-OXIDE CYCLASE FROM SACCHAROMYCES-CEREVISIAE [J].
BALLIANO, G ;
VIOLA, F ;
CERUTI, M ;
CATTEL, L .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 293 (01) :122-129
[3]   3-CARBOXY-4-NITROPHENYL-DITHIO-1,1',2-TRISNORSQUALENE - A SITE-DIRECTED INACTIVATOR OF YEAST OXIDOSQUALENE CYCLASE [J].
BALLIANO, G ;
GROSA, G ;
MILLA, P ;
VIOLA, F ;
CATTEL, L .
LIPIDS, 1993, 28 (10) :903-906
[4]  
BARIK S, 1993, PCR PROTOCOLS CURREN, P277
[5]   INTRACELLULAR PROTEIN TOPOGENESIS [J].
BLOBEL, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (03) :1496-1500
[6]  
CAUJOLLE R, 1991, PHARM ACTA HELV, V66, P237
[7]   A CONVENIENT SYNTHESIS OF [3-H-3]SQUALENE AND [3-H-3]-2,3-OXIDOSQUALENE [J].
CERUTI, M ;
GROSA, G ;
ROCCO, F ;
DOSIO, F ;
CATTEL, L .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (06) :577-585
[8]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF AZASQUALENES, BIS-AZASQUALENES AND DERIVATIVES [J].
CERUTI, M ;
BALLIANO, G ;
VIOLA, F ;
CATTEL, L ;
GERST, N ;
SCHUBER, F .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1987, 22 (03) :199-208
[9]  
DANG T, 2000, CHEM BIOL, V7, P463
[10]   INVITRO INHIBITION OF ANIMAL AND HIGHER-PLANTS 2,3-OXIDOSQUALENE-STEROL CYCLASES BY 2-AZA-2,3-DIHYDROSQUALENE AND DERIVATIVES, AND BY OTHER AMMONIUM-CONTAINING MOLECULES [J].
DURIATTI, A ;
BOUVIERNAVE, P ;
BENVENISTE, P ;
SCHUBER, F ;
DELPRINO, L ;
BALLIANO, G ;
CATTEL, L .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (15) :2765-2777